Result of AGM

RNS Number : 7213Q
Accrol Group Holdings PLC
22 October 2019
 

22 October 2019

 

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

Result of 2019 Annual General Meeting

 

Accrol, the leading independent tissue converter in the UK, announces that all of the resolutions set out in the Notice of AGM were passed by the requisite majority at the Company's AGM, held earlier today.

 

Details of the proxy votes received by the Company are as follows:

 

Resolution

For

Against

Total

Withheld


No. of votes

%

No. of votes

%

No. of votes

%

No. of votes

1.     To receive the Annual Report and Accounts

122,707,536

99.97

28,611

0.02

122,736,147

100.00

 

0

2.     To elect Simon Allport

118,764,933

96.82

3,889,105

3.17

122,654,038

100.00

 

82,109

3.     To appoint BDO as auditor

122,219,373

99.64

428,680

0.35

122,648,053

100.00

 

88,094

4.     To approve the directors' remuneration report

73,488,398

69.77

31,823,226

30.22

105,311,624

100.00

 

17,424,523

5.     To authorise the Directors to allot relevant securities

118,751,224

99.90

116,058

0.1

118,867,282

100.00

 

3,860,494

6.     To authorise the directors to allot equity securities for cash without making a pre-      emptive offer to shareholders*

122,605,671

99.91

116,058

0.09

122,721,729

100.00

 

6,047

 

*Special resolution

 

Notes:

 

1.

Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.

2.

Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3.

A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".

4.

The number of shares in issue on 22 October 2019 was 195,246,536 with no shares in treasury. 

5.

The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at www.accrol.com.

 

In compliance with the QCA Code, the Board notes the percentage of votes cast against Resolution 4 to approve the directors' remuneration report. Shareholders with significant holdings in the Company were consulted ahead of the vote and the Board remains open to further discussions.

 

Enquiries:

 

For further information, please contact:




Accrol Group Holdings plc


Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer




Zeus Capital Limited (Nominated Adviser & Broker) 


Dan Bate / Andrew Jones  

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000



Belvedere Communications Limited


Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Keeley Clarke (kclarke@belvederepr.com)

Tel: +44 (0) 7967 816 525

Llew Angus (langus@belvederpr.com)

Tel:  +44 (0) 7407 023 147

 

Notes to Editors

 

New Group website: www.accrol.com

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

 

Our vision is to deliver the best possible value to the UK consumer on essential everyday tissue products. We are shaking up the traditional tissue brands by delivering the quality the consumer demands for the price they want to pay.

 

The business operates from four sites in Lancashire:

 

•              A manufacturing, storage and distribution facility in Blackburn;

•              A storage and administrative centre in Blackburn;

•              A facial tissue plant, also in Blackburn; and

•              A manufacturing, storage and distribution facility in Leyland.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGUUURRKWARUAA
UK 100

Latest directors dealings